Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptor-positive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?

Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptor-positive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?

Correct staging is the most crucial for the treatment outcome in cancer management. Molecular imaging with 18F-fluoroestradiol (FES) positron emission tomography-computed tomography (PET-CT) targets estrogen receptor (ER) and may have a higher incremental value in diagnosis by aiding specificity. We...

Full description

Bibliographic Details
Main Authors: Manoj Gupta, Anupama Datta, Partha S Choudhury, Maria Dsouza, Ullas Batra, Anil Mishra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:World Journal of Nuclear Medicine
Subjects:
18F-fluorodeoxyglucose positron emission tomography-computed tomography
18F-fluoroestradiol positron emission tomography-computed tomography
diagnostic strength
estrogen receptor-positive breast cancer
incremental value
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2017;volume=16;issue=2;spage=133;epage=139;aulast=Gupta

Internet

http://www.wjnm.org/article.asp?issn=1450-1147;year=2017;volume=16;issue=2;spage=133;epage=139;aulast=Gupta

Similar Items